These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36330597)

  • 1. Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis.
    Ashour AA; El-Kamel AH; Mehanna RA; Mourad G; Heikal LA
    Drug Deliv; 2022 Dec; 29(1):3270-3280. PubMed ID: 36330597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway.
    Rong X; Liu J; Yao X; Jiang T; Wang Y; Xie F
    Stem Cell Res Ther; 2019 Mar; 10(1):98. PubMed ID: 30885249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
    Ashour AA; El-Kamel AH; Abdelmonsif DA; Khalifa HM; Ramadan AA
    Int J Nanomedicine; 2021; 16():8013-8033. PubMed ID: 34916792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.
    Ma L; Wei J; Zeng Y; Liu J; Xiao E; Kang Y; Kang Y
    Drug Deliv; 2022 Dec; 29(1):440-453. PubMed ID: 35099348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective Effects of Bioflavonoid Luteolin Using Self-Nanoemulsifying Drug Delivery System.
    Shakeel F; Alamer MM; Alam P; Alshetaili A; Haq N; Alanazi FK; Alshehri S; Ghoneim MM; Alsarra IA
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated lecithin-bile salt nanovesicles as a promising approach for effective skin delivery of luteolin to improve UV-induced skin damage in Wistar Albino rats.
    Abbas H; El Sayed NS; Ali ME; Elsheikh MA
    Colloids Surf B Biointerfaces; 2022 Mar; 211():112299. PubMed ID: 34953364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma.
    Elsayed MMA; Okda TM; Atwa GMK; Omran GA; Abd Elbaky AE; Ramadan AEH
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis.
    Li T; Yan Y; Wang B; Qian H; Zhang X; Shen L; Wang M; Zhou Y; Zhu W; Li W; Xu W
    Stem Cells Dev; 2013 Mar; 22(6):845-54. PubMed ID: 23002959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin-Loaded Nanoparticles for the Treatment of Melanoma.
    Fu QT; Zhong XQ; Chen MY; Gu JY; Zhao J; Yu DH; Tan F
    Int J Nanomedicine; 2023; 18():2053-2068. PubMed ID: 37101838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics.
    Elnaggar YS; Elsheikh MA; Abdallah OY
    Nanomedicine (Lond); 2018 Jan; 13(2):209-232. PubMed ID: 29199881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis.
    Radwan SAA; El-Maadawy WH; ElMeshad AN; Shoukri RA; Yousry C
    Pharm Res; 2020 Sep; 37(9):180. PubMed ID: 32875435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
    Wu B; Feng J; Guo J; Wang J; Xiu G; Xu J; Ning K; Ling B; Fu Q; Xu J
    Stem Cell Res Ther; 2022 Oct; 13(1):494. PubMed ID: 36195966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluations of Transdermally Delivered Luteolin Loaded Cationic Nanoemulsion: In Vitro and Ex Vivo Evaluations.
    Altamimi MA; Hussain A; Alshehri S; Imam SS; Alnemer UA
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
    Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
    Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive nanoemulsion enhances brain bioavailability of luteolin after intranasal administration and induces apoptosis to SH-SY5Y neuroblastoma cells.
    Diedrich C; Camargo Zittlau I; Schineider Machado C; Taise Fin M; Maissar Khalil N; Badea I; Mara Mainardes R
    Int J Pharm; 2022 Oct; 626():122142. PubMed ID: 36064075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel luteolin@pro-phytomicelles: In vitro characterization and in vivo evaluation of protection against drug-induced hepatotoxicity.
    Song K; Zhou L; Wang C; Yuan Z; Cao Q; Wu X; Li M
    Chem Biol Interact; 2022 Sep; 365():110095. PubMed ID: 35970426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway.
    Wang N; Li X; Zhong Z; Qiu Y; Liu S; Wu H; Tang X; Chen C; Fu Y; Chen Q; Guo T; Li J; Zhang S; Zern MA; Ma K; Wang B; Ou Y; Gu W; Cao J; Chen H; Duan Y
    J Nanobiotechnology; 2021 Dec; 19(1):437. PubMed ID: 34930304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
    Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
    Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling.
    Chen F; Li X; Zhao J; Geng J; Xie J; Xu B
    In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):567-576. PubMed ID: 32748023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.